Clinical Trial Update: A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition [Phase 3]

View source ↗

Summary

Pfizer-sponsored Phase 3 trial evaluating inhaled insulin for diabetes mellitus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Inhaled insulin (insulin)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus | Phase 3 | Status: TERMINATED